Health News Releases

July 31, 2014 11:00

Harlan Provides Expertise for Biologics and Biosimilars

Harlan Laboratories, Ltd. (www.harlan.com), a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS), http://goo.gl/At862O) business, is prep

July 25, 2014 09:50

UpToDate Adds Palliative Care as a Specialty

Wolters Kluwer Health (http://goo.gl/o2rWK), a leading global provider of information for healthcare professionals and students, announced today that it has added Palliative Care to UpToDate®, its evi

July 24, 2014 10:20

PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis

Today Biogen Idec (NASDAQ: BIIB) announced that the European Commission (EC) has granted marketing authorization for PLEGRIDYTM (peginterferon beta-1a) as a treatment for adults with relapsing-remitti

July 23, 2014 13:20

Iroko Pharmaceuticals Continues to Expand Commercialization of ZORVOLEX® With New Strategic Agreement in Latin America

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that its affiliate, Iroko Pharmaceuticals Inc., signed a licensin

July 18, 2014 13:10

Terumo BCT Opens Manufacturing Facility in Vietnam

Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced the opening of its new 91,440-square-meter facility near Ho Chi Minh City, Vietnam. The

July 18, 2014 10:30

Boehringer Ingelheim’s investigational therapy nintedanib* receives the first FDA Breakthrough Therapy designation in IPF

For non-U.S. Media Only Boehringer Ingelheim today announced that for the first time the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation for a treatment in idiopa

July 16, 2014 11:50

Iroko Pharmaceuticals Announces New Strategic Agreement to Commercialize ZORVOLEX® in Brazil

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that its affiliate, Iroko Pharmaceuticals Inc., has signed a lice

July 15, 2014 21:00

Harlan and Fluofarma Sign Strategic Collaboration Agreement

Harlan Laboratories, Ltd. (www.harlan.com), a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS, http://goo.gl/At862O) business, and Fluo

July 10, 2014 10:55

Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLA® in Ankylosing Spondylitis

Celgene Corporation (NASDAQ:CELG) today announced results of its phase III POSTURE study evaluating OTEZLA, the company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), in patients with acti

July 09, 2014 11:45

Boehringer Ingelheim’s volasertib showed in a Phase II study an improvement in overall survival in older AML patients

For media outside of the US/UK only Summary: Acute Myeloid Leukaemia (AML) is an aggressive and devastating blood cancer.1,2 It predominantly affects people over 60 and is one of the most common

July 09, 2014 09:40

Iroko Pharmaceuticals Announces First International Filing for ZORVOLEX®

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced the company affiliate’s first regulatory submission outside of th

July 09, 2014 02:10

Morinaga Milk Industry Co., Ltd. Unveils New Research Demonstrating the Superiority of Human Residential Bifidobacteria

Morinaga Milk Industry Co., Ltd. (www.morinagamilk.co.jp/english) (TOKYO:2264), the second largest dairy product company in Japan, today announced that Morinaga has discovered differences in potential

July 07, 2014 18:00

WIN Consortium in Personalized Cancer Medicine Welcomes Six New Member Organizations during the WIN 2014 Symposium

The Worldwide Innovative Networking (WIN) Consortium in personalized cancer medicine proudly announces that six new organizations were approved as WIN Consortium members during the Consortium’s 2014 W

July 03, 2014 07:00

U.S. Food & Drug Administration Grants Orphan Drug Designation for Galderma’s Trifarotene Molecule in the Treatment of Congenital Ichthyosis

Galderma announces that the U.S. FDA granted Orphan Drug Designation status for the company’s trifarotene molecule for the treatment of congenital ichthyosis. Based on this decision, Galderma plans to

July 02, 2014 17:20

COPD: Boehringer Ingelheim submits applications in Europe for tiotropium + olodaterol Respimat® fixed-dose combination in COPD

For media outside the US, the UK and Canada Boehringer Ingelheim today announced submission of Marketing Authorisation Applications in 31 European countries for the once-daily fixed-dose combinatio

July 02, 2014 13:55

Quintiles Completes Acquisition of Encore Health Resources

Quintiles today announced that it has completed the acquisition (http://goo.gl/bq5JiK) of Encore Health Resources (Encore, http://encorehealthresources.com), a leader in the health-information analyti

July 02, 2014 11:15

World Bank-Aided GNRC Plans Launch of Medi-Chopper Service in North-East India

GNRC (formerly known as Guwahati Neurological Research Centre) today unveiled plans to initiate air ambulance and medical outreach programme using helicopters to remote areas of North-east India. The

July 01, 2014 12:00

Quintiles’ Second Quarter 2014 Earnings Call Scheduled for Thursday, July 31st

Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the second quarter of 2014 prior to its quarterly earnings call on Thursday, July 31, 2014, at 8:00 a.m. EDT.

July 01, 2014 11:45

U.S. FDA grants Breakthrough Therapy Designation to Pradaxa® (dabigatran etexilate) specific investigational antidote

For media outside of the U.S., the UK & Canada only The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational antidote idarucizumab* (a humaniz

July 01, 2014 11:40

CHMP Recommends EU Approval of VIZAMYL™ (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque

GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). This opinion recommends the granting of a ma

June 25, 2014 18:00

China to Host World’s Largest Integrated Health Industry Event “tHIS” in 2015

Reed Sinopharm Exhibitions, the leading healthcare event organizer in China, announced Wednesday the launch of The Health Industry Summit (tHIS, www.thishealthsummit.com) in Shanghai. This new event,

June 25, 2014 14:08

Fast-Evolving US Cardiac Ablation Industry Affords Multiplying Niche Opportunities, Says Frost & Sullivan

The increasing prevalence of cardiac arrhythmias and availability of premium-priced innovative technologies are driving the cardiac ablation market in the U.S. Promising technologies, including balloo

June 25, 2014 11:25

ADEA to Host 5th International Women’s Leadership Conference along with International Workshop, Sept. 14-16, 2014

The American Dental Education Association (ADEA, www.adea.org), the premier association serving the dental education community, is hosting two meetings for today’s globally-minded dental education and

June 24, 2014 17:45

Ferring Pharmaceuticals and Roche collaborate to develop personalised infertility treatment

Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring’s human cell line derived recombinant follicle-stimulating hormone (hu

June 24, 2014 10:30

Quintiles Named a Best IT Workplace by Computerworld

Quintiles, the world’s largest biopharmaceutical services provider and a Fortune 500 company, has been named one of IDG Computerworld's 100 Best Places to Work in IT 2014 (www.computerworld.com), the

News by Region

News by Industry